896P Multiple radiomic biomarkers-based machine learning model to predict responses of surufatinib-treated advanced neuroendocrine tumor (NET): A multicenter exploratory study

Jingxi Xu(Chinese PLA General Hospital), Jingyi Yang, Chongshan Lin(Kangmei Pharmaceutical (China)), Kaifeng Nie, Xiwen Luo(Guangxi Normal University), W. Su(CK Hutchison (China)), Jingcheng Zhou, Chuanwei Zhao(Second People's Hospital of Yunnan Province), Suhang Fan(CK Hutchison (China))
Annals of Oncology
September 1, 2022
Cited by 0


Related Papers